|
The recession knocks this stock price down big time along with kndl, ppdi, crl, and cvd. Gabor Balthazar, Chairman of the Special Committee says "We believe this transaction is in the best interests of Life Sciences Research and its stockholders.” Are you selling at $8.50?
Rating :
 (No ratings) |
52/Male |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|